Approval comes as cases around the world increase, pressuring governments to speed up vaccination programs.
The World Health Organization has listed Modern’s COVID-19 vaccine for emergency use, the agency said Friday, the fifth time it has been given status to expedite the approval of its own shots at countries.
“The goal is for medicines, vaccines and diagnoses to be available as soon as possible to address the emergency,” the WHO said in a statement.
WHO Deputy Director-General Mariangela Simao said on Friday that it was important to have more vaccines available because of supply problems from other traits, including India, a major source of vaccines for the global vaccine-sharing program. COVAX.
India has restricted exports due to a crisis of home infections that has overwhelmed the country’s healthcare system.
Modern has announced this week a plan to expand its production network to increase its capacity to three billion doses in 2022.
The WHO Strategic Advisory Group on Immunization Experts (SAGE) had already recommended the Moderna vaccine in January for all age groups 18 years and older.
The shot of Pfizer and its German partner BionTech, a mRNA vaccine like Moderna’s, was the first vaccine to get a WHO emergency use listing in the last hours of 2020.
Since then, the WHO has added vaccines from AstraZeneca-SK Bio, Serum Institute of India and Johnson & Johnson to the list.
The United Nations health agency is still studying COVID-19 vaccines developed by Chinese manufacturers Sinopharm and Sinovac after an expanded review, with decisions scheduled for late next week.